South Korea Cell And Gene Therapy Thawing Equipment Market to 2032
Overview
The South Korea Cell And Gene Therapy Thawing Equipment Market is expected to reach a 61.80 USD Million by 2032 and is projected to grow at a CAGR of 24.88% from 2025 to 2032.
South Korea Cell And Gene Therapy Thawing Equipment Market 2018-2032 USD Million
South Korea Cell And Gene Therapy Thawing Equipment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 18.85 USD Million
- Projected Market Size (2032): 61.80 USD Million
- CAGR (2025-2032): 24.88%
Key Findings of South Korea Cell And Gene Therapy Thawing Equipment Market
- The South Korea Cell And Gene Therapy Thawing Equipment Market was valued at 18.85 USD Million in 2024.
- The South Korea Cell And Gene Therapy Thawing Equipment Market is likely to grow at a CAGR of 24.88% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cell Therapies in Sample Segment accounted for the largest share of the market with a revenue of 15.46 USD Million
- The fastest growing segment Blood Banks And Transfusion Centers in End User Segment grew Fastest with a CAGR of 27.05% during the forecast period from 2024 to 2032.
South Korea Cell And Gene Therapy Thawing Equipment Market Scope
- Others
- Third Party Distributors
- Direct Tender
- Others
- Gene Banks
- Cord Blood And Stem Cell Banks
- Biotechnology And Pharmaceutical Industry
- Research Laboratories And Academic Institutes
- Blood Banks And Transfusion Centers
- Hospitals And Diagnostic Laboratories
- Downstream Processing
- Upstream Processing
- Manual Thawing System
- Automatic Thawing System
- Gene Therapies
- Cell Therapies
- Portable
- Bench Top
South Korea Cell And Gene Therapy Thawing Equipment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 18.85 USD Million |
| Market Value in 2032 | 61.80 USD Million |
| CAGR (2025-2032) | 24.88% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, End User, Application, Type, Sample, Modality |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 18.85 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 18.85 USD Million in 2024.
Segments and Scope
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 13.30 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 26.28 % in forecast period 2025-2032.
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By End User
- Hospitals And Diagnostic Laboratories is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 6.59 USD Million in the year 2024.
- Blood Banks And Transfusion Centers is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 24.89 % in forecast period 2025-2032.
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By Application
- Upstream Processing is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 14.24 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 25.48 % in forecast period 2025-2032.
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By Type
- Automatic Thawing System is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 15.12 USD Million in the year 2024.
- Automatic Thawing System is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 25.26 % in forecast period 2025-2032.
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By Sample
- Cell Therapies is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 15.46 USD Million in the year 2024.
- Gene Therapies is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 24.55 % in forecast period 2025-2032.
-
South Korea Cell And Gene Therapy Thawing Equipment Market to 2032, By Modality
- Bench Top is the largest segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a revenue of 15.13 USD Million in the year 2024.
- Portable is the Fastest growing segment in South Korea Cell And Gene Therapy Thawing Equipment Market to 2032 with a Growth rate of 24.64 % in forecast period 2025-2032.
South Korea Cell And Gene Therapy Thawing Equipment Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Sartorius AG | |||
| Cytiva | |||
| Eppendorf | |||
South Korea Cell And Gene Therapy Thawing Equipment Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Cell And Gene Therapy Thawing Equipment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
South Korea Cell And Gene Therapy Thawing Equipment Market Scope
- Others
- Third Party Distributors
- Direct Tender
- Others
- Gene Banks
- Cord Blood And Stem Cell Banks
- Biotechnology And Pharmaceutical Industry
- Research Laboratories And Academic Institutes
- Blood Banks And Transfusion Centers
- Hospitals And Diagnostic Laboratories
- Downstream Processing
- Upstream Processing
- Manual Thawing System
- Automatic Thawing System
- Gene Therapies
- Cell Therapies
- Portable
- Bench Top
Frequently Asked Questions
South Korea Cell And Gene Therapy Thawing Equipment Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.